Method for loading NMN on liposome and application thereof

By using liposomes formed by phospholipids and cholesterol to wrap NMN, the problem that NMN is difficult to penetrate the skin barrier is solved, the effective conversion of NMN into NAD+ in the skin is achieved, and the stability and efficacy of cosmetics are significantly improved, solving the problem of NMN NMN stability and immunogenicity issues.

CN118986776APending Publication Date: 2024-11-22NANJING HANRUI BIOTECHNOLOGY CO LTD
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202411138615.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-19
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing NMN uses are difficult to convert into NAD+ in cells through the skin barrier, which has problems such as poor stability, easy oxidation and immunogenicity, which limits its potential applications.

Method used

The NMN is encapsulated by liposomes formed by phospholipids and cholesterol, transport NMN to the endothelial cell layer through the transdermal nature of the liposomes, converting it into NAD+ in the skin, and increasing NMN through a double-layer membrane structure and charge regulator. stability and load capacity.

Benefits of technology

It effectively passes through the skin barrier, converts NMN into NAD+, delays the aging of skin cells, and has anti-wrinkle, freckle removal, anti-inflammatory, sun protection and other effects, improving the safety and stability of cosmetics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005000097850000081
    Figure BDA0005000097850000081
  • Figure BDA0005000097850000091
    Figure BDA0005000097850000091
Patent Text Reader

Abstract

The invention belongs to the technical field of biology, and particularly relates to a method for loading NMN on lipidosome, which comprises the following steps: S1, preparing an oil phase: dissolving a film-forming agent and an inducer in polyol, heating and dissolving to obtain the oil phase; s2, preparing a water phase: weighing a proper amount of NMN, dissolving the NMN in water, and heating to obtain the water phase; and S3, preparing liposome loaded with NMN: adding the water phase into the oil phase while performing ultrasonic homogenization, cooling, adding water, and uniformly stirring to obtain the liposome loaded with NMN. According to the invention, the liposome containing components such as water, glycerol, 1, 2-pentanediol, PEG-40 hydrogenated castor oil, isosorbide dimethyl ether, lecithin, hexyldecanol, amylopectin and the like and NMN are taken as raw materials, NMN is loaded onto the liposome, the NMN can efficiently penetrate through a skin barrier to be converted into NAD < + > in an endothelial cell layer to play a role, the liposome is more convenient to obtain, the cost is lower, and the NMN can be applied to the preparation of NAD < + >. Meanwhile, the liposome has relatively good entrapment capability on the NMN, and meanwhile, oxidation of the NMN is effectively prevented.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of biotechnology, and in particular to a method for loading NMN into liposomes and an application thereof. Background Art

[0002] The transdermal drug delivery system is a new drug delivery system. Due to its more humanized drug delivery and treatment characteristics and the continuous development of transdermal technology, it has become one of the fastest growing areas in the pharmaceutical industry. It refers to a new dosage form in which drugs are delivered on the surface of the skin, and the drugs penetrate the skin layers at a certain rate and enter the human body's blood circulation through the capillaries to reach effective blood drug concentrations and achieve systemic or local therapeutic effects. Compared with oral and intravenous administration, transdermal drug delivery has the advantages of avoiding the first-pass effect of the liver and gastrointestinal tract, reducing fluctuations in blood drug concentrations, avoiding drug irritation to the gastrointestinal tract, non-invasive administration, and strong compliance, because drug absorption is not affected by factors such as pH, food, and transit time in the digestive tract.

[0003] Active ingredients are used in the cosmetics field to achieve various effects such as moisturizing, whitening, anti-aging, and anti-oxidation, among which a large part of active ingredients are water-soluble. As we all know, the stratum corneum is more likely to allow fat-soluble substances to penetrate, while only a very small part of water-soluble active ingredients can penetrate the stratum corneum, so the function of water-soluble active ingredients cannot be fully exerted. For the transdermal absorption of water-soluble active ingredients, liposome encapsulation and other methods can be used. Liposomes are a substance with low toxicity, low immunity, and good cell compatibility. They can simultaneously load water-soluble, fat-soluble and macromolecular drugs, and have received extensive attention in the field of drug delivery, especially transdermal drug delivery technology.

[0004] Liposomes are artificial spherical vesicles composed of one or more concentric lipid bilayers surrounding a water core. They first appeared in a paper published by Bangham et al. in 1964. The lipid bilayer structure of liposomes changes the pharmacokinetic characteristics of drugs after binding to drugs. Liposomes have advantages such as good biocompatibility, no biological toxicity, complete biodegradability and no immunogenicity. These advantages determine that liposomes can be used as carriers for drug delivery. Drugs can be encapsulated in liposomes to reduce the number of times the drug directly contacts sensitive tissues, increase stability, prolong the circulation time in the body, reduce the dosage, and reduce side effects. (Research progress in liposome preparation technology) In the drug loading process, liposomes first carry drugs through the intercellular pathway to penetrate the stratum corneum to the deep layer of the skin, and then release the drugs, so that the drugs are distributed to the deep layer of the skin and promote drug absorption through the skin.

[0005] NMN, full name: β-nicotinamide mononucleotide, is a naturally occurring biologically active nucleotide that exists in various organisms and is widely distributed in the extracellular matrix and intercellular matrix of animal tissues. Currently, NMN may be able to better accomplish the various roles that nicotinamide has been proven to play in skin anti-aging, because NMN can be converted into NAD+ (nicotinamide adenine dinucleotide) more directly and efficiently, thereby activating various downstream signaling pathways that regulate cell cycle, cell lifespan, DNA repair and energy metabolism. It has the effects of anti-oxidation and reducing oxidative stress.

[0006] In 2013, the P&G Japan team used a two-photon microscope to observe the skin of 80 Asian women. The data showed that the NAD+ / NADH content in epidermal cells decreased significantly with age, which may be directly related to cell aging and photodamage. Supplementing NAD+ can slow down cell aging.

[0007] In addition, clinical verification and long-term application have shown that NMN not only has significant effects such as anti-wrinkle, freckle removal and pigmentation removal, but also has anti-inflammatory, sun protection, health care, and anti-aging effects. However, due to its poor stability at room temperature, easy oxidation, short biological half-life, easy enzymatic hydrolysis, and immunogenicity, its potential applications are limited.

[0008] According to the literature reports on current human clinical data on NMN skin care, although NMN can be converted into NAD+ in the human body, whether topical NMN can pass through the skin barrier and be converted into NAD+ in cells has become a research problem that needs to be solved urgently. Summary of the invention

[0009] 1. Technical issues to be resolved

[0010] In view of the shortcomings of the prior art, the present invention provides a method for loading NMN with liposomes and its application. Liposomes are mainly bilayer microvesicles with a structure similar to that of a biological membrane, which are formed by phospholipids and cholesterol or other additives. They have good encapsulation capacity for both water-soluble and fat-soluble drugs, and can effectively prevent the oxidation of NMN. They can effectively penetrate the skin barrier to reach the endothelial cell layer. By utilizing the transdermal property of liposomes to load NMN, NMN can be effectively transported to the endothelial layer, where it is converted into NAD+ in the skin, helping to promote collagen production, regulate the skin cell cycle, delay skin cell aging, and whiten the skin. This solves the problem that topical NMN is not convenient to penetrate the skin barrier and be converted into NAD+ in cells.

[0011] (II) Technical solution

[0012] In order to achieve the above-mentioned purpose, the present invention specifically adopts the following technical solutions:

[0013] A method for loading NMN into liposomes comprises the following steps:

[0014] S1. Prepare the oil phase: add accurately weighed 10-20% glycerol, 5-10% 1,2-pentanediol, 1-5% PEG-40 hydrogenated castor oil, 1-5% dimethyl isosorbide, 1-5% lecithin, 1-5% hexyldecanol, and 0.1-10% pullulan solution into a conical flask in sequence, stir magnetically, and stir in a water bath at a temperature of 10-40° C. to completely dissolve them to obtain the oil phase;

[0015] S2. Prepare an aqueous phase: dissolve NMN in water so that the mass percentage of NMN is 0.03-1%, and heat to 75-85° C. to obtain an aqueous phase;

[0016] S3. Preparation of liposome-loaded NMN: Mix appropriate amounts of oil phase and aqueous phase together, stir the resulting mixed solution for 30 minutes, and use a high-speed disperser homogenizer to granulate the solution. The homogenization time is 10 minutes and the homogenization speed is 8000 r / min. The homogenized solution is ultrasonically operated for 20 minutes. Finally, filter with a 0.22 μm filter membrane to obtain the liposome filtrate.

[0017] Furthermore, the liposomes are composed of the following components by mass percentage: 40-70% water, 10-20% glycerol, 5-10% 1,2-pentanediol, 1-5% PEG-40 hydrogenated castor oil, 1-5% dimethyl isosorbide, 1-5% lecithin, 1-5% hexyldecanol, and 0.1-10% pullulan.

[0018] Furthermore, the liposome has a double-layer membrane structure, including an outer membrane and an inner membrane, the outer membrane includes a film-forming agent and an inducer, and the inner membrane includes a film-forming agent and an inducer;

[0019] Among them, the inducer is embedded between the film-forming agents;

[0020] Wherein, both the outer layer film and the inner layer film further include a charge adjusting agent, the charge adjusting agent is embedded between the film-forming agents, and the charge adjusting agent is adjacent to or not adjacent to the inducing agent;

[0021] The liposomes also include ligands of epidermal cell receptors, which are located outside the outer membrane and are bound to the outer membrane.

[0022] Application of liposomes prepared by a liposome-loaded NMN method in cosmetics;

[0023] Among them, the above-mentioned liposomes are used in cosmetics that can promote the skin's absorption of active substances through ligands of epidermal cell receptors.

[0024] (III) Beneficial effects

[0025] Compared with the prior art, the present invention provides a method for loading NMN into liposomes and its application, which has the following beneficial effects:

[0026] 1. The present invention uses liposomes containing water, glycerol, 1,2-pentanediol, PEG-40 hydrogenated castor oil, dimethyl isosorbide, lecithin, hexyldecanol, pullulan and other ingredients and NMN as raw materials, and loads NMN onto the liposomes. This method can enable NMN to efficiently pass through the skin barrier and be converted into NAD+ in the endothelial cell layer to exert its effect. Liposomes are more convenient to obtain and have lower costs, and are easy to promote. At the same time, liposomes have a good encapsulation capacity for NMN and effectively prevent the oxidation of NMN.

[0027] 2. In the present invention, NMN itself is a single substance in the body's cells. It is relatively safe as a cosmetic emulsion, and the skin care product can prevent skin roughness and aging, reduce the appearance of skin wrinkles, and keep the skin bright and elastic.

[0028] 3. The liposome-loaded NMN extracted by the method of the present invention can effectively penetrate the epidermis to reach the endothelial cells to exert anti-aging, barrier repair and skin whitening effects, and has great clinical and economic value. DETAILED DESCRIPTION

[0029] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.

[0030] A method for loading NMN into liposomes comprises the following steps:

[0031] S1. preparing the oil phase: dissolving the film former and the inducer in the polyol, heating and dissolving, to obtain the oil phase;

[0032] Specifically, 10-20% of glycerol, 5-10% of 1,2-pentanediol, 1-5% of PEG-40 hydrogenated castor oil, 1-5% of isosorbide dimethyl ether, 1-5% of lecithin, 1-5% of hexyldecanol, and 0.1-10% of pullulan solution are added into a conical flask in sequence, and stirred magnetically in a water bath at a temperature of 10-40° C. to completely dissolve the mixture, thereby obtaining an oil phase;

[0033] S2. Prepare the aqueous phase: weigh an appropriate amount of NMN and dissolve it in water, heat it, and obtain the aqueous phase;

[0034] The details are as follows: dissolve NMN in water so that the mass percentage of NMN is 0.03-1%, heat to 75-85°C, and obtain an aqueous phase.

[0035] S3. Preparation of liposomes loaded with NMN: adding the aqueous phase to the oil phase while ultrasonically homogenizing, adding water after cooling, and stirring evenly to obtain liposomes loaded with NMN;

[0036] The details are as follows: an appropriate amount of oil phase and water phase are mixed together, the obtained mixed solution is stirred for 30 minutes, the above solution is subjected to granulation by a high-speed disperser homogenizer, the homogenization time is 10 minutes, the homogenization speed is 8000r / min, the homogenized solution is subjected to ultrasonic operation, the ultrasonic time is 20 minutes, and finally filtered with a 0.22μm filter membrane to obtain a liposome filtrate.

[0037] The liposomes are composed of the following components by mass percentage: 40-70% water, 10-20% glycerol, 5-10% 1,2-pentanediol, 1-5% PEG-40 hydrogenated castor oil, 1-5% isosorbide dimethyl ether, 1-5% lecithin, 1-5% hexyldecanol, and 0.1-10% amylopectin.

[0038] Wherein, the liposome has a double-layer membrane structure, including an outer membrane and an inner membrane, the outer membrane includes a film-forming agent and an inducer, and the inner membrane includes a film-forming agent and an inducer;

[0039] Among them, the inducer is embedded between the film-forming agents;

[0040] Wherein, both the outer layer film and the inner layer film further include a charge adjusting agent, the charge adjusting agent is embedded between the film-forming agents, and the charge adjusting agent is adjacent to or not adjacent to the inducing agent;

[0041] Among them, the liposomes also include ligands for epidermal cell receptors, which are located outside the outer membrane and bound to the outer membrane;

[0042] The above liposome structure can effectively encapsulate a certain amount of active substances with a high encapsulation rate, making it easier for the active substances to penetrate into the skin. According to actual needs, a certain amount of hyaluronic acid or its salt can be appropriately added to improve the stability of the liposome.

[0043] Application of liposomes prepared by a liposome-loaded NMN method in cosmetics;

[0044] Among them, the above-mentioned liposomes are used in cosmetics that can promote the skin's absorption of active substances through ligands of epidermal cell receptors.

[0045] The present invention generally and / or specifically describes the materials and test methods used in the test. In the following examples, unless otherwise specified, % means wt%, i.e., weight percentage. The reagents or instruments used without indicating the manufacturer are all conventional reagent products that can be obtained commercially, among which sodium hyaluronate was purchased from Bloomage Biotechnology Co., Ltd.

[0046] Example 1

[0047] In the process of preparing the oil phase, accurately weighed 10% glycerol, 5% 1,2-pentanediol, 1% PEG-40 hydrogenated castor oil, 1% dimethyl isosorbide, 1% lecithin, 1% hexyldecanol, and 0.1% pullulan solution are sequentially added into a conical flask, and stirred magnetically and in a water bath at a stirring temperature of 10° C. to completely dissolve them to obtain the oil phase;

[0048] During the preparation of the aqueous phase, NMN was dissolved in water so that the mass percentage of NMN was 0.03%, and heated to 75° C. to obtain an aqueous phase;

[0049] During the process of liposome loading with NMN, appropriate amounts of oil phase and water phase were mixed together, the resulting mixed solution was stirred for 30 minutes, and the above solution was granulated by a high-speed disperser homogenizer with a homogenization time of 10 minutes and a homogenization speed of 8000 r / min. The homogenized solution was ultrasonically operated for 20 minutes, and finally filtered with a 0.22 μm filter membrane to obtain the liposome filtrate.

[0050] Example 2

[0051] In the process of preparing the oil phase, accurately weighed 20% glycerol, 10% 1,2-pentanediol, 5% PEG-40 hydrogenated castor oil, 5% dimethyl isosorbide, 5% lecithin, 5% hexyldecanol, and 10% pullulan solution are sequentially added into a conical flask, and stirred magnetically and in a water bath at 40° C. to completely dissolve them to obtain the oil phase;

[0052] During the preparation of the aqueous phase, NMN was dissolved in water so that the mass percentage of NMN was 1%, and heated to 85° C. to obtain an aqueous phase;

[0053] During the process of liposome loading with NMN, appropriate amounts of oil phase and water phase were mixed together, the resulting mixed solution was stirred for 30 minutes, and the above solution was granulated by a high-speed disperser homogenizer with a homogenization time of 10 minutes and a homogenization speed of 8000 r / min. The homogenized solution was ultrasonically operated for 20 minutes, and finally filtered with a 0.22 μm filter membrane to obtain the liposome filtrate.

[0054] Example 3

[0055] In the process of preparing the oil phase, accurately weighed 15% glycerol, 7% 1,2-pentanediol, 2% PEG-40 hydrogenated castor oil, 2% dimethyl isosorbide, 2% lecithin, 2% hexyldecanol, and 6% pullulan solution are sequentially added into a conical flask, and stirred magnetically and in a water bath at 25° C. to completely dissolve them to obtain the oil phase;

[0056] During the preparation of the aqueous phase, NMN was dissolved in water so that the mass percentage of NMN was 0.6%, and heated to 80° C. to obtain an aqueous phase;

[0057] During the process of liposome loading with NMN, appropriate amounts of oil phase and water phase were mixed together, the resulting mixed solution was stirred for 30 minutes, and the above solution was granulated by a high-speed disperser homogenizer with a homogenization time of 10 minutes and a homogenization speed of 8000 r / min. The homogenized solution was ultrasonically operated for 20 minutes, and finally filtered with a 0.22 μm filter membrane to obtain the liposome filtrate.

[0058] Experimental Examples 1-3 were tested for stability. The particle size and Zeta potential were detected by Anton Paar Litesizer 500. The appearance of the liposomes was observed under a microscope. The results are shown in the following table.

[0059] The encapsulation efficiency of the active substance was tested by ultrafiltration centrifugation: a certain proportion of the liposome solution was diluted, a certain amount of the solution was accurately weighed, and placed in an ultrafiltration centrifuge tube; the liposome samples of the embodiment and the comparative example were centrifuged at a suitable speed and time; after centrifugation, the content of the active substance in the separated aqueous solution was detected, and the content of the active substance in the feed solution was compared to obtain the content of the encapsulated active substance. The test results are shown in the following table.

[0060]

[0061]

[0062] In summary, the liposome structure described in the present application has good stability. When the liposome encapsulates active substances, it can achieve stable and efficient encapsulation of the active substances, can keep the active substances more stable at high temperatures, and has better skin permeability. In addition, water is added during the preparation process, so that the obtained liposomes have good dispersibility in aqueous solution, reduced viscosity, increased fluidity, and can be quickly dissolved in water, which improves the convenience of the liposomes when used and is easy to add into various dosage forms.

[0063] Finally, it should be noted that the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A method for loading NMN into liposomes, characterized in that: The following steps are involved: S1. preparing the oil phase: dissolving the film former and the inducer in the polyol, heating and dissolving, to obtain the oil phase; S2. Prepare the aqueous phase: weigh an appropriate amount of NMN and dissolve it in water, heat it, and obtain the aqueous phase; S3. Prepare liposomes loaded with NMN: add the aqueous phase to the oil phase while ultrasonically homogenizing. After cooling, add water and stir evenly to obtain liposomes loaded with NMN.

2. A method for loading NMN into liposomes according to claim 1, characterized in that: The liposome is composed of the following components by mass percentage: 40-70% water, 10-20% glycerol, 5-10% 1,2-pentanediol, 1-5% PEG-40 hydrogenated castor oil, 1-5% isosorbide dimethyl ether, 1-5% lecithin, 1-5% hexyldecanol, and 0.1-10% amylopectin.

3. A method for loading NMN into liposomes according to claim 1, characterized in that: During the oil phase preparation process, accurately weighed 10-20% glycerol, 5-10% 1,2-pentanediol, 1-5% PEG-40 hydrogenated castor oil, 1-5% isosorbide dimethyl ether, 1-5% lecithin, 1-5% hexyldecanol, and 0.1-10% amylopectin solution are sequentially added into a conical flask, and magnetic stirring is performed. The stirring temperature in a water bath is 10-40° C. to completely dissolve the amylopectin to obtain the oil phase.

4. The method for loading NMN into liposomes according to claim 1, characterized in that: During the preparation of the aqueous phase, NMN is dissolved in water so that the mass percentage of NMN is 0.03-1%, and the water is heated to 75-85° C. to obtain an aqueous phase.

5. The method for loading NMN into liposomes according to claim 1, characterized in that: During the liposome loading process of NMN, an appropriate amount of oil phase and aqueous phase are mixed together, the obtained mixed solution is stirred for 30 minutes, and the above solution is subjected to granulation by a high-speed disperser homogenizer. The homogenization time is 10 minutes and the homogenization speed is 8000r / min. The homogenized solution is subjected to ultrasonic operation for 20 minutes, and finally filtered with a 0.22μm filter membrane to obtain the liposome filtrate.

6. The method for loading NMN into liposomes according to claim 1, characterized in that: The liposome has a double-layer membrane structure, including an outer membrane and an inner membrane, wherein the outer membrane includes a film-forming agent and an inducer, and the inner membrane includes a film-forming agent and an inducer; Among them, the inducer is embedded between the film-forming agents; Wherein, both the outer layer film and the inner layer film further include a charge adjusting agent, the charge adjusting agent is embedded between the film-forming agents, and the charge adjusting agent is adjacent to or not adjacent to the inducing agent; The liposomes also include ligands of epidermal cell receptors, which are located outside the outer membrane and are bound to the outer membrane.

7. Use of liposomes prepared by the method for loading NMN on liposomes according to any one of claims 1 to 6 in cosmetics; in, The liposomes mentioned above are used in cosmetics that can promote the absorption of active substances by the skin through the ligands of epidermal cell receptors.

Citation Information

Cited By

  • Pet staple food food easy to absorb and preparation method thereof

    CN119908420A

  • Composition containing NMN supramolecular structure and preparation method and application thereof

    CN122424072A